Computer-aided drug design:
- Chang YJ, Nguyen U, Liu JJ, Li SR, Chao ST, Lai HC, Lin YF, Hsu KC, Lu CH* and Lin CW*. Combining virtual screening with cis-/trans-cleavage enzymatic assays effectively reveals broad-spectrum inhibitors that target the main proteases of SARS-CoV-2 and MERS-CoV. Antiviral Research (2023), 216: 105653.
- Lu CH, Chang HT, Hsu LF, Lee MH, Cheng J, Wu DC and Lin WY*. In Silico and In Vitro Screening of Serine Racemase Agonist and In Vivo Efficacy on Alzheimers Disease Drosophila melanogaster. Pharmaceuticals (2023), 16(2): 280.
- Lu CH, Chung WM, Tsai CH, Cheng JC, Hsu KC and Tzeng HE*. In vitro characterization of a small molecule PD-1 inhibitor that targets the PD-l/PD-L1 interaction. Scientific Reports (2022), 12, Article number: 303.
- Chang YJ, Yeh CY, Cheng JC, Huang YQ, Hsu KC, Lin YF and Lu CH*. Potent sialic acid inhibitors that target influenza A virus hemagglutinin. Scientific Reports (2021), 11, Article number: 8637.